Transport of cisplatin in rat brain following microinfusion: an analysis - PubMed (original) (raw)
Transport of cisplatin in rat brain following microinfusion: an analysis
P F Morrison et al. J Pharm Sci. 1986 Feb.
Abstract
The post-microinfusion transport of cis-diamminedichloroplatinum(II) (cisplatin) in rat brain has been modeled as a linear diffusion-reaction-permeation process. The model has been used to analyze the experimental data of Kroin and Penn to obtain the macromolecular binding constant of cisplatin in the brain, k = 0.0050 +/- 0.0023 min-1, and the capillary permeability, p = (9.0 +/- 4.4) X 10(-7) cm/s. Inclusion of saturation effects led to the same p value and a higher k value of 0.007 min-1. The corresponding diffusion length is 0.8 mm. The reaction constant is similar to those reported for plasma (0.008 min-1) and muscle (0.004 min-1), and the permeability value is within the range predicted by correlation with the permeability-octanol/water partition coefficient. Fits to data were accomplished with mathematical expressions giving the average total platinum concentration in saggital cerebellar sections which were not subdivided. Both time-dependent and steady-state solutions were obtained for the transport model, the former predicting a half-time to steady state of 3 h. Boundary effects were also investigated. Concentration profiles, calculated for a point source and for a 23-gauge cannula, were shown to differ by 7%. Similar comparisons between two profiles, one computed for an infinite diffusion range and another computed for drug diffusion into a flowing cerebrospinal fluid (CSF) at a finite range of 3 mm, showed differences of less than 3%. Free and bound drug forms, protein turnover, and CSF uptake have been accounted for as well as the percent infusate recoveries at 100 and 160 h reported by Kroin and Penn.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Brain iron homeostasis.
Moos T. Moos T. Dan Med Bull. 2002 Nov;49(4):279-301. Dan Med Bull. 2002. PMID: 12553165 Review. - How fatty acids of different chain length enter and leave cells by free diffusion.
Kamp F, Hamilton JA. Kamp F, et al. Prostaglandins Leukot Essent Fatty Acids. 2006 Sep;75(3):149-59. doi: 10.1016/j.plefa.2006.05.003. Epub 2006 Jul 7. Prostaglandins Leukot Essent Fatty Acids. 2006. PMID: 16829065 Review.
Cited by
- The use of convection-enhanced delivery with liposomal toxins in neurooncology.
Fiandaca MS, Berger MS, Bankiewicz KS. Fiandaca MS, et al. Toxins (Basel). 2011 Apr;3(4):369-97. doi: 10.3390/toxins3040369. Epub 2011 Mar 31. Toxins (Basel). 2011. PMID: 22069714 Free PMC article. Review. - A mathematical model of the impact of infused targeted cytotoxic agents on brain tumours: implications for detection, design and delivery.
Wein LM, Wu JT, Ianculescu AG, Puri RK. Wein LM, et al. Cell Prolif. 2002 Dec;35(6):343-61. doi: 10.1046/j.1365-2184.2002.00246.x. Cell Prolif. 2002. PMID: 12427253 Free PMC article. - Biologically-derived nanomaterials for targeted therapeutic delivery to the brain.
Curley SM, Cady NC. Curley SM, et al. Sci Prog. 2018 Sep 1;101(3):273-292. doi: 10.3184/003685018X15306123582346. Epub 2018 Aug 2. Sci Prog. 2018. PMID: 30071918 Free PMC article. Review. - Drug delivery to the central nervous system.
Nance E, Pun SH, Saigal R, Sellers DL. Nance E, et al. Nat Rev Mater. 2022 Apr;7(4):314-331. doi: 10.1038/s41578-021-00394-w. Epub 2021 Dec 3. Nat Rev Mater. 2022. PMID: 38464996 Free PMC article. - Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.
Deurloo MJ, Kop W, van Tellingen O, Bartelink H, Begg AC. Deurloo MJ, et al. Cancer Chemother Pharmacol. 1991;27(5):347-53. doi: 10.1007/BF00688856. Cancer Chemother Pharmacol. 1991. PMID: 1998994
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous